Maryland-based biotech Novavax experienced a clinical hold on its late-stage tri...
After the FDA approves Johnson & Johnson MedTech’s Varipulse technology for the ...
AbbVie saw its valuation drop by around $40 billion following disappointing resu...
Maximizing the potential AI/data-driven model of drug discovery requires the tec...
In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo ...
AstraZeneca announced that its new weight-loss medication, which was licensed fr...
Roche first entered into an agreement with Orionis Biosciences in 2023 and paid ...
AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through...
Izervay by Astellas and Syfovre by Apellis are the major rivals in the United St...
Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney ...
A mid-phase trial featuring Gilead Sciences and Merck & Co.’s once-weekly HIV co...
The latest research on Arcus Biosciences’ experimental HIF-2a inhibitor suggests...
Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after i...
Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit...
Common conditions in women such as PCOS, menopause, and endometriosis often lead...
Novartis is investing over $70 million in Chengdu Baiyu Pharmaceutical to bolste...
